| Literature DB >> 19475504 |
Lucy E Napper1, Dennis G Fisher, Grace L Reynolds, Mark E Johnson.
Abstract
Few studies have investigated the optimal length of recall period for self-report of sex and drug-use behaviors. This meta-analysis of 28 studies examined the test-retest reliability of three commonly used recall periods: 1, 3, and 6 months. All three recall periods demonstrated acceptable test-retest reliability, with the exception of recall of needle sharing behaviors and 6-months recall of some sex behaviors. For most sex behaviors, a recall period of 3 months was found to produce the most reliable data; however, 6 months was best for recalling number of sex partners. Overall, shorter periods were found to be more reliable for recall of drug-use behaviors, though the most reliable length of recall period varied for different types of drugs. Implications of the findings and future directions for research are discussed.Entities:
Mesh:
Year: 2009 PMID: 19475504 PMCID: PMC2814040 DOI: 10.1007/s10461-009-9575-5
Source DB: PubMed Journal: AIDS Behav ISSN: 1090-7165
Description of studies reporting test-retest reliability of drug use variables
| Study | Sample | Measure (recall period) | Reliabilities |
|---|---|---|---|
| Blake et al. ( | 127 US military personnel | Marijuana use (30 days) | 1.00 |
| Carey et al. ( | 132 psychiatric outpatients. 64% male; mean age 44.1 years (US sample) | TLFB: Marijuana use and total drug use (30 and 90 days) | .94 (30 days) .91–.94 (90 days) |
| Day et al. ( | 27 heroin injectors; 70% male; mean age 32 years (Australian sample) | TLFB: Number of days used heroin, cocaine, amphetamines, benzodiazepines, cannabis (6 months) | .67–.88 |
| Dowling-Guyer et al. ( | 218 out-of-treatment drug users; 74% male; mean age 39.9 years (US samples) | RBA: Crack, cocaine, heroin, marijuana, speedball, amphetamine and methadone use, and injection drug use (30 days) | .69–.87 |
| Ehrman and Robbins ( | 59 heroin users in an outpatient methadone treatment program; 98% male; mean age 41 years (US sample) | TLFB: Heroin and cocaine use (30 and 180 days) | .77–.82 (30 days) .91–.95 (180 days) |
| Fals-Stewart et al. ( | 113 substance abuse outpatients; 71% male; mean age 27.4 years (US sample) | TLFB: Use of amphetamines, cannabis, cocaine, hallucinogens, opiates, sedatives (30 and 90 days) | .72–.93 (30 days) .71–.92 (90 days) |
| Johnson et al. ( | 259 out-of-treatment drug users; 67.6% male; mean age 38.2 years (US sample) | RBFA: Use of marijuana, crack, cocaine, heroin, speedball, opiates, amphetamines and injection behavior (30 days) | .48–.96 |
| Krenz et al. ( | 36 outpatient and inpatient drug users; 68% male; mean age 29.7 years (Swiss sample) | ASI: Heroin, methadone, other opiates, barbiturates, sedatives, cocaine, amphetamines, cannabis & hallucinogens use (30 days) | .80–1.0 |
| Levy et al. ( | 93 adolescents attending primary-care medical clinics; 28% male; age range 12–19 years (US sample) | TLFB: Marijuana use (30, 90 days) | .70–.89 (30 days) .83–.93 (90 days) |
| Martin et al. ( | 103 young adults accessing outpatient and inpatient drug treatment; 81% male; mean age 20.4 years (Canadian sample) | DUHF: Use of cannabis, cocaine and hallucinogens (30, 90, and 180 days) | .30–.88 (30 days) .34–.90 (90 days) .49–.91 (180 days) |
| Matt et al. ( | 88 cigarette smokers; 51% male; mean age 29.5 years (US sample) | Use of marijuana, amphetamines, cigarettes and alcohol (30 days) | .90–.99 |
| Miele et al. ( | 175 inpatient and outpatient drug treatment patients; 62% male; mean age 35.6 years (US sample) | SDSS: Number of days used cocaine, heroin, cannabis and sedatives (30 days) | .50–.82 |
| Myers et al. ( | 196 IDUs and sex partners of IDUs; 74% male (US sample) | AIA: Frequency of marijuana, crack, cocaine, amphetamine, heroin, speedball, methadone, other opiates use, sharing works (6 months) | −.11–.93 |
| Needle et al. ( | 214 drug users; 70.3% male; mean age 38 years (US sample) | RBA: Crack, cocaine, heroin use (30 days) | .69–.78 |
| Ross et al. ( | 23 injecting drug users; 87% male; mean age 28 years (Australian sample) | Number people accepted used needle/syringe from (6 months) | .56 |
| Sacks et al. ( | 158 homeless adults (US sample) | TLFB: Number days used cocaine, cannabis, any illicit drugs (30 days, 6 months) | .72–.81 (30 days) .89–.93 (6 months) |
| Scheurich et al. ( | 30 alcohol-dependent inpatients; 73% male; mean age 44.7 years (German sample) | Form 90: Tranquilizer and sedative use (90 days) | .64–1.00 |
| Slesnick and Tonigan ( | 37 homeless youth; 49% male; age range 12–17 years (US sample) | Form 90: Cocaine and marijuana use (90 days) | .40–.97 |
| Westerberg et al. ( | 34 treatment-seeking clients; 53% male; mean age 36.3 years (US sample) | Form 90: Cocaine, opiates, marijuana, stimulants, tranquilizer use (90 days) | .02–.80 |
| Williams et al. ( | 392 drug users; 69% male; mean age 36.2 years (US sample) | Computer assisted and face-to-face interviews: Crack, cocaine, heroin, speedball (30 days) | .22–.91 |
ASI Addiction Severity Index. DUHF Drug Use History Form. AIA AIDS Initial Assessment Questionnaire. TLFB Timeline Followback. RBA Risk Behavior Assessment. RBFA Risk Behavior Follow-up Assessment. SDSS Substance Dependence Severity Scale
aAuthors from these studies provided additional unpublished data
Description of studies reporting test-retest reliability of sex behavior variables
| Study | Sample | Measure (recall period) | Reliabilities |
|---|---|---|---|
| Carey et al. ( | 66 psychiatric outpatients; 50% male; age range 18–60 years (US sample) | TLFB: Number of partners, vaginal and oral sexual events (1, 3 months) | .71–.97 (1 month) .80–.95 (3 months) |
| Dowling-Guyer et al. ( | 218 out-of-treatment drug users; 74% male; mean age 39.9 years (US sample) | RBA: Number of partners, frequency of sex (vaginal, oral, anal), condom use (30 days) | .07–1.00 |
| Johnson et al. ( | 259 out-of-treatment drug users; 67.6% male; mean age 38.2 years (US sample) | RBFA: Number of partners, times had vaginal sex, condom use, times traded sex for money or drugs (30 days) | .57–.87 |
| McKinnon et al. ( | 16 sexually active psychiatric patients; 66.7% male; age range 18–59 years (US sample) | Sexual Risk Behavior Assessment Schedule: Number of partners, sexual episodes and proportion vaginal intercourse (6 months) | .60–.88 |
| McLaws et al. ( | 30 men; majority were male prostitutes (Australian sample) | Number of partners, frequency anal sex, oral sex and condom use (30 days) | .08–.98 |
| Myers et al. ( | 196 IDUs and sex partners of IDUs; 74% male (US sample) | Number of partners, condom use, frequency of vaginal, oral, anal sex for male respondents only (6 months) | .12–1.00 |
| Needle et al. ( | 214 drug users; 70.3% male; mean age 38 years (US sample) | RBA: Number of partners, IDU partners, times had vaginal sex, days had sex (30 days) | .66–.83 |
| Ross et al. ( | 23 injecting drug users; 87% male; mean age 28 years (Australian sample) | % time used condoms for vaginal and oral sex (6 months) | −.40–.80 |
| Schrimshaw et al. ( | 64 gay/lesbian/bisexual youth; 55% male; mean age 18.2 years (US sample) | SERBES: Number of same-sex partners, oral, anal, and vaginal-digital encounters (3 months) | −.01–1.00 |
| Sieving et al. ( | 152 sexually active 13 to18 year old females seeking reproductive health services (US sample) | Number of partners and frequency of vaginal sex (3 months, 6 months) | .53–.86 (3 months) .48–.82 (6 months) |
| Sneed et al. ( | 83 Thai and Korean participants; 51% male; mean age 29 years (US sample) | Adapted version of the NIMH Multisite HIV Prevention Trial survey: Vaginal, anal and oral sex, condom use (90 days) | .97–1.00 |
| Sohler et al. ( | 39 homeless men with severe mental illness; age range 24–57 years (US sample) | SERBAS: Number of partners, vaginal sex, anal sex, condom use (6 months) | .49–.90 |
| Weinhardt et al. ( | 110 college students; 53.6% male; mean age 19.7 years | TLFB and single item measures: Number partners and vaginal and oral sex practices (1 month and 3 months) | .85–.98 (30 days) .81–.97 (3 months) |
| Williams et al. ( | 392 drug users; 69% male; mean age 36.2 years (US sample) | Computer assisted and face-to-face interviews: Number of partners, drug-using partners, vaginal sex (30 days) | −.13–.99 |
RBA Risk Behavior Assessment. RBFA Risk Behavior Follow-up Assessment. TLFB Timeline Followback. SERBAS Sexual Risk Behavior Assessment Schedule
aAuthors from this study provided additional unpublished data
Test-retest reliability of drug use variables
| Risk behavior variable | 30 days recall | 3 months recall | 6 months recall |
|---|---|---|---|
| All drug variablesa | .898 18 (1718) .89–.91 | .844 7 (458) .81–.87 | .833 6 (440) .80–.86 |
| Marijuana usea | .923 12 (1202) .91–.93 | .848 6 (450) .82–.87 | .846 4 (456) .82–.87 |
| Cocaine/crack usea | .800 14 (1367) .78–.82 | .875 4(198) .84–.90 | .865 5 (320) .83–.89 |
| Amphetaminesa | .930 6 (175) .91–.95 | .796 2 (78) .69–.87 | |
| Heroina | .804 11 (1002) .78–.83 | .831 3 (181) .78–.87 | |
| Shared worksa | .691 4 (662) .65–.73 | .731 3 (461) .69–.77 |
Cells were left empty where data were not available
aLine 1 contains estimated population correlation. Line 2 contains the number of correlations, and the total sample size in parenthesis. Line 3 contains the 95% confidence intervals of the estimated population correlation
Test-retest reliability of sex behavior variables
| Risk behavior variable | 30 days recall | 3 months recall | 6 months recall |
|---|---|---|---|
| All sex variablesa | .817 15 (1040) .86–.89 | .949 6 (361) .94–.96 | .822 5 (289) .78–.86 |
| Vaginal sex onlya | .836 13 (759) .81–.86 | .968 4 (172) .96–.98 | .616 4 (132) .49–.72 |
| Anal sexa | .897 2 (102) .85–.93 | .577 3 (122) .44–.69 | |
| Oral sexa | .768 4 (215) .71–.82 | .897 5(192) .86–.92 | .610 2 (73) .44–.74 |
| Number of partnersa | .786 14 (973) .76–.81 | .848 3 (282) .81–.88 | .930 4 (314) .91–.94 |
Cells were left empty where data were not available
aLine 1 contains estimated population correlation. Line 2 contains the number of correlations, and the total sample size in parenthesis. Line 3 contains the 95% confidence intervals of the estimated population correlation